The goal of this clinical trial is to evaluate accuracy of continuous glucose monitoring device called 'Dexcom G7' in patients undergoing cardiac surgery.
Study Type
OBSERVATIONAL
Enrollment
100
Continuous glucose monitoring device (Dexcom G7) will be applied to patients undergoing cardiac surgery intraoperatively and postoperatively (maximum 10 days)
Seoul National University Hospital
Seoul, South Korea
RECRUITINGMARD
mean absolute relative difference
Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)
Bland-Altman analysis
mean difference, bias, 95% limits of agreement
Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)
ISO criteria
Satisfaction of 2013 ISO (International Organization of Standardization) criteria
Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)
DTS error grid
DTS (Diabtetes Technology Society) error grid
Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.